Skip to main content
Premium Trial:

Request an Annual Quote

'Announcement We've Been Waiting For'

"My Twitter feed just exploded," Matthew Herper says. "No one is talking about much else right now," the Broad Institute's Chad Nusbaum tells Forbes. "This is the megaton sequencing announcement we've been waiting for," Nick Loman writes at Pathogens: Genes and Genomes.

We are, of course, referring to Oxford Nanopore's announcement of two new DNA strand-sequencing systems at the Advances in Genome Biology and Technology meeting held on Marco Island, Fla., last week. (Our sister publication In Sequence has more on the GridIon and MinIon.)

In addition to sending shockwaves across the blogs and on Twitter — "ILMN [Illumina] cheers storing genomes on a USB stick while Oxford Nanopore was showing sequencing genomes with a USB stick," @rob_carlson writes, while @GenomeBiology says "Oxford Nanopore had everyone talking at lunch. Is the MinIon going to be the next-next-gen? Wow," and @Copenhagenomics calls the new technology "a potential game changer" — Nanopore's announcements shook up the stock market, presumably causing the declines observed in some sequencing companies' share values Friday afternoon. (GenomeWeb Daily News breaks those declines down.)

"Too many amazing @nanopore tweets to retweet them all," Loman says. Daily Scan couldn't agree more.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.